You are here

Heart Failure


The FDA has expanded its premarket approval for Impella heart pumps to include treatment for heart failure associated with cardiomyopathy leading to cardiogenic shock, device manufacturer Abiomed announced Feb. 13.

Exposure to noise pollution has been shown to negatively impact cardiovascular health. But researchers have only recently begun to explore exactly how noise can harm health. A study published online Feb. 6 in the Journal of the American College of Cardiology explored the connection between noise and arterial hypertension, myocardial infarction, heart failure and stroke.

Aspirin is ineffective in preventing heart attack, stroke and death in heart failure patients without atrial fibrillation (AFib), according to a nationwide study in Denmark. In fact, patients on aspirin may be more likely to have myocardial infarction (MI) or be rehospitalized for heart failure, Christian Madelaire, MD, and colleagues reported in JACC: Heart Failure.

Certain breast cancer therapies, including popular HER-2 targeted treatments, could be harmful to the heart in patients already at an increased risk for cardiovascular disease (CVD), the American Heart Association reported this week in a new scientific statement.

Only 30 percent of Medicare patients who received ventricular assist devices (VADs) in 2014 attended cardiac rehabilitation, but those patients enjoyed significant decreases in hospitalizations and mortality over the following year, according to a study in JACC: Heart Failure.


Recent Headlines

Optimal drug dosing after heart failure extends patients’ careers

Patients who receive target or near-target doses of evidence-based medicine (EBM) are more likely to continue working after a heart failure hospitalization, according to a study of Danish individuals published Dec. 6 in JACC: Heart Failure.

Heart cell damage during non-cardiac surgery can be fatal, but often unnoticed

Damage inflicted during non-cardiac surgery can reach heart cells and significantly raise a patient’s risk of mortality for up to one year after the procedure, according to research published this week in the American Heart Association journal Circulation.

Engineers develop living heart muscle large enough to cover area damaged by MI

Biomedical engineers at Duke University have created a fully functioning heart muscle from pluripotent stem cells that is large enough to patch over damaged areas in human heart attack patients.

Heart failure-related hospitalizations, mortalities see downward trend

Heart failure-related hospitalizations and in-hospital mortalities have decreased significantly since the turn of the millennium, the American Heart Association has reported, despite a general increase in the burden of heart failure (HF) comorbidities.

Researchers detail trends of increasing heart failure across UK

The number of new people diagnosed with heart failure each year in the United Kingdom is now similar to that of the most four common types of cancer combined, according to the most comprehensive review of heart failure statistics in the U.K. to date, published online Nov. 21 in The Lancet.

30% of heart patients still taking prescribed statins 3 years later

While 71 percent of heart patients are prescribed statins after hospitalization for heart disease, cerebrovascular disease and peripheral artery disease, just 37.4 percent retain that medication regimen a year later, researchers in Salt Lake City reported this week.

Novel discovery suggests MRIs after cardiac arrest could predict patient outcomes

Patients who suffer brain damage after cardiac arrest could benefit from magnetic resonance (MR) imaging following their stabilization—a measure that has been shown to predict clinical outcomes through mapping brain activity, according to new research published in the American journal Radiology.

AHA: Blacks living shorter lives due to CVD, stroke

African Americans are dying an average of 3.4 years before white Americans, a significant gap that’s attributable to more prevalent cardiovascular disease (CVD) and risk factors in the black population, the American Heart Association (AHA) reported in a scientific statement published Monday in Circulation.

Children awaiting heart transplant survive longer with VADs than ECMO

Ventricular assist devices (VADs) foster improved survival for children awaiting heart transplantation when compared to the current standard of extracorporeal membrane oxygenation (ECMO), according to a new study in the Journal of the American College of Cardiology.

Researchers call for more patient-centered designs, outcomes in cardiovascular trials

Cardiovascular research has traditionally focused on hard clinical endpoints such as markers of disease progression, adverse events and death. But now researchers are calling for more studies that incorporate the viewpoints of patients and caregivers, both in trial design and execution and in measuring outcomes like quality of life, time off work, out-of-pocket expense and caregiver burden.